These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26002735)
21. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Xu X; Zhang XA; Wang DW Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627 [TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450-derived eicosanoids and inflammation in liver diseases. Shoieb SM; El-Ghiaty MA; Alqahtani MA; El-Kadi AOS Prostaglandins Other Lipid Mediat; 2020 Apr; 147():106400. PubMed ID: 31733338 [TBL] [Abstract][Full Text] [Related]
23. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Simopoulos AP Exp Biol Med (Maywood); 2008 Jun; 233(6):674-88. PubMed ID: 18408140 [TBL] [Abstract][Full Text] [Related]
24. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. Gabbs M; Leng S; Devassy JG; Monirujjaman M; Aukema HM Adv Nutr; 2015 Sep; 6(5):513-40. PubMed ID: 26374175 [TBL] [Abstract][Full Text] [Related]
25. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. Fischer R; Konkel A; Mehling H; Blossey K; Gapelyuk A; Wessel N; von Schacky C; Dechend R; Muller DN; Rothe M; Luft FC; Weylandt K; Schunck WH J Lipid Res; 2014 Jun; 55(6):1150-64. PubMed ID: 24634501 [TBL] [Abstract][Full Text] [Related]
26. The Functions of Cytochrome P450 ω-hydroxylases and the Associated Eicosanoids in Inflammation-Related Diseases. Ni KD; Liu JY Front Pharmacol; 2021; 12():716801. PubMed ID: 34594219 [TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory ω-3 endocannabinoid epoxides. McDougle DR; Watson JE; Abdeen AA; Adili R; Caputo MP; Krapf JE; Johnson RW; Kilian KA; Holinstat M; Das A Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6034-E6043. PubMed ID: 28687674 [TBL] [Abstract][Full Text] [Related]
28. Endogenous synthesis of n-3 PUFA modifies fatty acid composition of kidney phospholipids and eicosanoid levels in the fat-1 mouse. Kelton D; Lysecki C; Aukema H; Anderson B; Kang JX; Ma DW Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):169-77. PubMed ID: 23994161 [TBL] [Abstract][Full Text] [Related]
29. Systematic metabolomic analysis of eicosanoids after omega-3 polyunsaturated fatty acid supplementation by a highly specific liquid chromatography-tandem mass spectrometry-based method. Zhang X; Yang N; Ai D; Zhu Y J Proteome Res; 2015 Apr; 14(4):1843-53. PubMed ID: 25736083 [TBL] [Abstract][Full Text] [Related]
30. n-6 and n-3 polyunsaturated fatty acids down-regulate cytochrome P-450 2B1 gene expression induced by phenobarbital in primary rat hepatocytes. Li CC; Lii CK; Liu KL; Yang JJ; Chen HW J Nutr Biochem; 2006 Oct; 17(10):707-15. PubMed ID: 16517146 [TBL] [Abstract][Full Text] [Related]
31. The opposing effects of n-3 and n-6 fatty acids. Schmitz G; Ecker J Prog Lipid Res; 2008 Mar; 47(2):147-55. PubMed ID: 18198131 [TBL] [Abstract][Full Text] [Related]
32. Role of CYP eicosanoids in the regulation of pharyngeal pumping and food uptake in Caenorhabditis elegans. Zhou Y; Falck JR; Rothe M; Schunck WH; Menzel R J Lipid Res; 2015 Nov; 56(11):2110-23. PubMed ID: 26399467 [TBL] [Abstract][Full Text] [Related]
33. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. Hassan IR; Gronert K J Immunol; 2009 Mar; 182(5):3223-32. PubMed ID: 19234220 [TBL] [Abstract][Full Text] [Related]
34. Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450. Oliw EH; Bylund J; Herman C Lipids; 1996 Oct; 31(10):1003-21. PubMed ID: 8898299 [TBL] [Abstract][Full Text] [Related]
35. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Zordoky BN; El-Kadi AO Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140 [TBL] [Abstract][Full Text] [Related]
36. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors. Dawczynski C; Massey KA; Ness C; Kiehntopf M; Stepanow S; Platzer M; Grün M; Nicolaou A; Jahreis G Clin Nutr; 2013 Oct; 32(5):686-96. PubMed ID: 23332800 [TBL] [Abstract][Full Text] [Related]
37. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids. Medhora M; Dhanasekaran A; Gruenloh SK; Dunn LK; Gabrilovich M; Falck JR; Harder DR; Jacobs ER; Pratt PF Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):19-29. PubMed ID: 17164129 [TBL] [Abstract][Full Text] [Related]
38. Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders. Shahabi P; Siest G; Meyer UA; Visvikis-Siest S Pharmacol Ther; 2014 Nov; 144(2):134-61. PubMed ID: 24882266 [TBL] [Abstract][Full Text] [Related]
39. Metabolomics revealed decreased level of omega-3 PUFA-derived protective eicosanoids in pregnant women with pre-eclampsia. Liu Y; Zu L; Cai W; Cheng Q; Hua T; Peng L; Li G; Zhang X Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):705-710. PubMed ID: 30983029 [TBL] [Abstract][Full Text] [Related]
40. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis. Calder PC Proc Nutr Soc; 2008 Nov; 67(4):409-18. PubMed ID: 18847518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]